| Year |
Citation |
Score |
| 2023 |
Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, Singh M, Torrini C, Zhang BS, Bandyopadhyay S, Daniels KA, Alvarez-Breckenridge C, Dahal A, Brehm MA, Brastianos PK. CDK4/6 inhibition sensitizes intracranial tumors to PD-1 blockade in preclinical models of brain metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37611074 DOI: 10.1158/1078-0432.CCR-23-0433 |
0.328 |
|
| 2023 |
Kim AE, Nieblas-Bedolla E, de Sauvage MA, Brastianos PK. Leveraging translational insights toward precision medicine approaches for brain metastases. Nature Cancer. 4: 955-967. PMID 37491527 DOI: 10.1038/s43018-023-00585-0 |
0.344 |
|
| 2023 |
Brastianos PK, Twohy E, Geyer S, Gerstner ER, Kaufmann TJ, Tabrizi S, Kabat B, Thierauf J, Ruff MW, Bota DA, Reardon DA, Cohen AL, De La Fuente MI, Lesser GJ, Campian J, et al. BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas. The New England Journal of Medicine. 389: 118-126. PMID 37437144 DOI: 10.1056/NEJMoa2213329 |
0.309 |
|
| 2023 |
Mair MJ, Bartsch R, Le Rhun E, Berghoff AS, Brastianos PK, Cortes J, Gan HK, Lin NU, Lassman AB, Wen PY, Weller M, van den Bent M, Preusser M. Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours. Nature Reviews. Clinical Oncology. PMID 37085569 DOI: 10.1038/s41571-023-00756-z |
0.307 |
|
| 2022 |
Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, et al. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102371. PMID 36288512 DOI: 10.1200/JCO.21.02371 |
0.464 |
|
| 2022 |
Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, et al. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell & Melanoma Research. PMID 35912544 DOI: 10.1111/pcmr.13059 |
0.316 |
|
| 2022 |
Schiff D, Messersmith H, Brastianos PK, Brown PD, Burri S, Dunn IF, Gaspar LE, Gondi V, Jordan JT, Maues J, Mohile N, Redjal N, Stevens GHJ, Sulman EP, van den Bent M, et al. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2200333. PMID 35561283 DOI: 10.1200/JCO.22.00333 |
0.431 |
|
| 2022 |
Alvarez-Breckenridge C, Remon J, Piña Y, Nieblas-Bedolla E, Forsyth P, Hendriks L, Brastianos PK. Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 42: 1-19. PMID 35522917 DOI: 10.1200/EDBK_352320 |
0.385 |
|
| 2021 |
Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102314. PMID 34932393 DOI: 10.1200/JCO.21.02314 |
0.574 |
|
| 2021 |
Steindl A, Brastianos PK, Preusser M, Berghoff AS. Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles. Neuro-Oncology Advances. 3: v35-v42. PMID 34859231 DOI: 10.1093/noajnl/vdab105 |
0.353 |
|
| 2021 |
Prakadan SM, Alvarez-Breckenridge CA, Markson SC, Kim AE, Klein RH, Nayyar N, Navia AW, Kuter BM, Kolb KE, Bihun I, Mora JL, Bertalan MS, Shaw B, White M, Kaplan A, ... ... Brastianos PK, et al. Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases. Nature Communications. 12: 7007. PMID 34824235 DOI: 10.1038/s41467-021-27207-6 |
0.308 |
|
| 2021 |
Kim AE, Wang GM, Waite KA, Elder S, Fine A, Ahluwalia MS, Brat D, Mehta MP, Page R, Dunbar E, Calderone HM, Robins DS, DeVitto R, Willmarth NE, Barnholtz-Sloan JS, ... Brastianos PK, et al. Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases. Neuro-Oncology Practice. 8: 662-673. PMID 34777835 DOI: 10.1093/nop/npab042 |
0.319 |
|
| 2021 |
Singh M, Dahal A, Brastianos PK. Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases. Current Protocols. 1: e284. PMID 34762346 DOI: 10.1002/cpz1.284 |
0.343 |
|
| 2021 |
Prakadan SM, Alvarez-Breckenridge CA, Markson SC, Kim AE, Klein RH, Nayyar N, Navia AW, Kuter BM, Kolb KE, Bihun I, Mora JL, Bertalan MS, Shaw B, White M, Kaplan A, ... ... Brastianos PK, et al. Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases. Nature Communications. 12: 5955. PMID 34642316 DOI: 10.1038/s41467-021-25860-5 |
0.304 |
|
| 2021 |
Pellerino A, Brastianos PK, Rudà R, Soffietti R. Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches. Cancers. 13. PMID 34207653 DOI: 10.3390/cancers13122888 |
0.379 |
|
| 2021 |
Pellerino A, Brastianos PK, Rudà R, Soffietti R. Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches. Cancers. 13. PMID 34207653 DOI: 10.3390/cancers13122888 |
0.379 |
|
| 2021 |
Fujio S, Juratli TA, Takajo T, Arita K, Nagano Y, Yoshimoto K, Nayyar N, Curry WT, Martinez-Lage M, Cahill DP, Barker FG, Brastianos PK. Craniopharyngiomas, Including Recurrent Cases, Lack TERT Promoter Hotspot Mutations. Neurologia Medico-Chirurgica. PMID 33967180 DOI: 10.2176/nmc.rc.2020-0339 |
0.336 |
|
| 2021 |
Liu D, Lin JR, Robitschek EJ, Kasumova GG, Heyde A, Shi A, Kraya A, Zhang G, Moll T, Frederick DT, Chen YA, Wang S, Schapiro D, Ho LL, Bi K, ... ... Brastianos PK, et al. Evolution of delayed resistance to immunotherapy in a melanoma responder. Nature Medicine. PMID 33941922 DOI: 10.1038/s41591-021-01331-8 |
0.326 |
|
| 2021 |
Karimi S, Mansouri S, Nassiri F, Bunda S, Singh O, Brastianos PK, Dunn IF, Zadeh G. Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status. Journal of Neuro-Oncology. 151: 443-449. PMID 33611710 DOI: 10.1007/s11060-020-03584-8 |
0.567 |
|
| 2020 |
Ebright RY, Zachariah MA, Micalizzi DS, Wittner BS, Niederhoffer KL, Nieman LT, Chirn B, Wiley DF, Wesley B, Shaw B, Nieblas-Bedolla E, Atlas L, Szabolcs A, Iafrate AJ, Toner M, ... ... Brastianos PK, et al. HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nature Communications. 11: 6311. PMID 33298946 DOI: 10.1038/s41467-020-20144-w |
0.356 |
|
| 2020 |
Nieblas-Bedolla E, Nayyar N, Singh M, Sullivan RJ, Brastianos PK. Emerging Immunotherapies in the Treatment of Brain Metastases. The Oncologist. PMID 33103803 DOI: 10.1002/onco.13575 |
0.356 |
|
| 2020 |
Starkweather CK, Choi BD, Alvarez-Breckenridge C, Brastianos PK, Oh K, Wang N, Shih H, Nahed BV. Initial Approach to the Patient with Multiple Newly Diagnosed Brain Metastases. Neurosurgery Clinics of North America. 31: 505-513. PMID 32921347 DOI: 10.1016/J.Nec.2020.05.002 |
0.335 |
|
| 2020 |
Aquilanti E, Brastianos PK. Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons. Neurosurgery. PMID 32302389 DOI: 10.1093/Neuros/Nyaa095 |
0.301 |
|
| 2020 |
Shih DJH, Nayyar N, Bihun I, Dagogo-Jack I, Gill CM, Aquilanti E, Bertalan M, Kaplan A, D'Andrea MR, Chukwueke U, Ippen FM, Alvarez-Breckenridge C, Camarda ND, Lastrapes M, McCabe D, ... ... Brastianos PK, et al. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nature Genetics. PMID 32203465 DOI: 10.1038/S41588-020-0592-7 |
0.364 |
|
| 2020 |
Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, ... Brastianos P, et al. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32041819 DOI: 10.1136/Jnnp-2019-322257 |
0.302 |
|
| 2020 |
Brastianos PK, Twohy E, Anders CK, Iafrate AJ, Kaufman PA, Cohen JV, Heist RS, Gerstner ER, Kaufmann TJ, Geyer S, Hoffman L, Kumthekar P, Barker FG, Carter SL, Brown PD, et al. Alliance A071701: Genomically guided treatment trial in brain metastases. Journal of Clinical Oncology. 38: TPS2573-TPS2573. DOI: 10.1200/jco.2020.38.15_suppl.tps2573 |
0.425 |
|
| 2020 |
Kim AE, Chang K, Beers A, Emblem KE, Kalpathy-Cramer J, Lee EQ, Lin NU, Nayak L, Chukwueke UN, Oh KS, Shih HA, White M, Lawrence DP, Moy B, Cohen JV, ... ... Brastianos PK, et al. Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition. Journal of Clinical Oncology. 38: 2529-2529. DOI: 10.1200/Jco.2020.38.15_Suppl.2529 |
0.308 |
|
| 2020 |
Vidula N, Niemierko A, Malvarosa G, Brastianos P, Blouch E, Shannon K, Isakoff S, Wander S, Spring L, Younger J, Price K, Moy B, Juric D, Ellisen L, Bardia A. Abstract P4-09-06: Brain metastases (BM) in patients with metastatic breast cancer (MBC) and circulating cell-free DNA (cfDNA) somaticBRCAmutations Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P4-09-06 |
0.344 |
|
| 2020 |
Nayyar N, Singh M, Stocking J, Brehm M, Brastianos P. TMOD-05. EXTRACRANIAL TUMORS INFLUENCE INTRACRANIAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN PRE-CLINICAL MODELS OF MELANOMA BRAIN METASTASIS Neuro-Oncology. 22: ii228-ii228. DOI: 10.1093/neuonc/noaa215.956 |
0.301 |
|
| 2020 |
Juratli T, Nayyar N, Young M, Subramanian M, Brastianos P, Lin D. PATH-40. INTRAGENIC DMD DELETIONS ARE THE MOST COMMON RECURRENT GENOMIC ALTERATIONS IN ESTHESIONEUROBLASTOMA Neuro-Oncology. 22: ii173-ii173. DOI: 10.1093/neuonc/noaa215.721 |
0.358 |
|
| 2020 |
Alvarez-Breckenridge C, Markson S, Stocking J, Lastrapes M, Nayyar N, Bertalan M, Kaplan A, Alvarez MM, Izar B, Suva M, Sullivan R, Cahill D, Carter S, Brastianos P. IMMU-01. SINGLE CELL SEQUENCING OF MELANOMA BRAIN METASTASES UNVEILS HETEROGENEITY OF THE TUMOR MICROENVIRONMENT IN RESPONSE TO IMMUNE CHECKPOINT BLOCKADE Neuro-Oncology. 22: ii104-ii104. DOI: 10.1093/neuonc/noaa215.432 |
0.405 |
|
| 2020 |
Singh M, Nayyar N, Brastianos P. DDRE-02. THERAPEUTIC TARGETING OF BRAIN METASTASIS WITH ERK INHIBITOR LY3214996 USING A NOVEL IN VIVO MODEL OF LUNG-TO-BRAIN METASTASIS Neuro-Oncology. 22: ii61-ii61. DOI: 10.1093/neuonc/noaa215.247 |
0.363 |
|
| 2019 |
Boire A, Brastianos PK, Garzia L, Valiente M. Brain metastasis. Nature Reviews. Cancer. PMID 31780784 DOI: 10.1038/s41568-019-0220-y |
0.34 |
|
| 2019 |
Williams SR, Juratli TA, Castro BA, Lazaro TT, Gill CM, Nayyar N, Strickland MR, Babinski M, Johnstone SE, Frosch MP, Silverman IM, Ely HA, Kaplan AB, D'Andrea MR, Bihun IV, ... ... Brastianos PK, et al. Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent Mutations in Foramen Magnum Meningiomas. Journal of Neurological Surgery. Part B, Skull Base. 80: 562-567. PMID 31750041 DOI: 10.1055/S-0038-1676821 |
0.328 |
|
| 2019 |
D'Andrea MR, Gill CM, Umphlett M, Tsankova NM, Fowkes M, Bederson JB, Brastianos PK, Shrivastava RK. Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era. The Oncologist. PMID 31694894 DOI: 10.1634/Theoncologist.2019-0306 |
0.319 |
|
| 2019 |
Zhu L, Narloch JL, Onkar S, Joy M, Broadwater G, Luedke C, Hall A, Kim R, Pogue-Geile K, Sammons S, Nayyar N, Chukwueke U, Brastianos PK, Anders CK, Soloff AC, et al. Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. Journal For Immunotherapy of Cancer. 7: 265. PMID 31627744 DOI: 10.1186/S40425-019-0755-1 |
0.308 |
|
| 2019 |
Horbinski C, Ligon KL, Brastianos P, Huse JT, Venere M, Chang S, Buckner J, Cloughesy T, Jenkins RB, Giannini C, Nabors LB, Wen PY, Aldape KJ, Lukas RV, Galanis E, et al. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. Neuro-Oncology. PMID 31276167 DOI: 10.1093/Neuonc/Noz119 |
0.499 |
|
| 2019 |
Ippen FM, Grosch JK, Subramanian M, Kuter BM, Liederer BM, Plise EG, Mora JL, Nayyar N, Schmidt SP, Giobbie-Hurder A, Martinez-Lage M, Carter SL, Cahill DP, Wakimoto H, Brastianos PK. Targeting the PI3K/Akt/mTOR-pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases. Neuro-Oncology. PMID 31173106 DOI: 10.1093/Neuonc/Noz105 |
0.324 |
|
| 2019 |
Brastianos P, Davies MA, Margolin K, Yu HA. Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune Oncology. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. e59-e69. PMID 31099629 DOI: 10.1200/EDBK_241345 |
0.3 |
|
| 2019 |
Chukwueke UN, Brastianos PK. Precision Medical Approaches to the Diagnoses and Management of Brain Metastases. Current Treatment Options in Oncology. 20: 49. PMID 31062107 DOI: 10.1007/s11864-019-0649-y |
0.308 |
|
| 2019 |
Venur VA, Cohen JV, Brastianos PK. Targeting Molecular Pathways in Intracranial Metastatic Disease. Frontiers in Oncology. 9: 99. PMID 30886831 DOI: 10.3389/fonc.2019.00099 |
0.335 |
|
| 2019 |
Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, et al. Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. Neuro-Oncology. 21: 424-427. PMID 30883663 DOI: 10.1093/Neuonc/Noz034 |
0.331 |
|
| 2019 |
Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, et al. Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802085. PMID 30883246 DOI: 10.1200/Jco.18.02085 |
0.331 |
|
| 2019 |
Alvarez-Breckenridge C, Giobbie-Hurder A, Gill CM, Bertalan M, Stocking J, Kaplan A, Nayyar N, Lawrence DP, Flaherty KT, Shih HA, Oh K, Batchelor TT, Cahill DP, Sullivan R, Brastianos P. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control. The Oncologist. PMID 30796152 DOI: 10.1634/theoncologist.2018-0306 |
0.33 |
|
| 2019 |
Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junk L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Rudà R, Weller M, van den Bent MJ, Vogelbaum MA, et al. Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications. Neuro-Oncology. PMID 30668804 DOI: 10.1093/Neuonc/Noz012 |
0.33 |
|
| 2019 |
Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, et al. Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology. 21: i18-i31. PMID 30649489 DOI: 10.1093/Neuonc/Noy136 |
0.443 |
|
| 2019 |
Nahed BV, Alvarez-Breckenridge C, Brastianos PK, Shih H, Sloan A, Ammirati M, Kuo JS, Ryken TC, Kalkanis SN, Olson JJ. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors. Neurosurgery. PMID 30629227 DOI: 10.1093/neuros/nyy542 |
0.363 |
|
| 2019 |
Wang N, Cohen JV, Goss NC, Bertalan M, Keeley MC, Cahill DP, Oh KS, Brastianos PK. The impact of a dedicated multidisciplinary tumor board on care for patients with brain metastases. Journal of Clinical Oncology. 37: e13585-e13585. DOI: 10.1200/JCO.2019.37.15_SUPPL.E13585 |
0.417 |
|
| 2019 |
Smyth ENN, Tiu RV, Willard MD, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P. Clinical characteristics, treatment (Tx) patterns, and overall survival (OS) in advanced (Adv) NSCLC patients (Pts) with and without brain metastases (BM). Journal of Clinical Oncology. 37: 2035-2035. DOI: 10.1200/Jco.2019.37.15_Suppl.2035 |
0.307 |
|
| 2019 |
Willard MD, Smyth ENN, Tiu RV, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P. Genomic characterization of lung tumors and metastatic (Met) sites in advanced (Adv) NSCLC. Journal of Clinical Oncology. 37: 2014-2014. DOI: 10.1200/Jco.2019.37.15_Suppl.2014 |
0.457 |
|
| 2019 |
Juratli T, Jones P, Wang N, Subramanian M, Aylwin S, Odia Y, Rostami E, Gudjonsson O, Shaw B, Cahill D, Uhm J, Galanis E, Barker F, Santagata S, Brastianos P. Rare-04. Targeted Treatment Of Papillary Craniopharyngiomas Harboring Brafv600E Mutations Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.927 |
0.341 |
|
| 2019 |
Wang N, Cohen J, Goss N, Bertalan M, Keeley M, Parsons M, Nahed B, Cahill D, Oh K, Brastianos P. Innv-27. The Impact Of A Dedicated Multidisciplinary Tumor Board On Care For Patients With Brain Metastases Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.568 |
0.458 |
|
| 2019 |
Nayyar N, Shih D, Bihun I, Dagogo-Jack I, Gill C, Aquilanti E, Bertalan M, Kaplan A, D’Andrea M, Chukwueke U, Ippen F, Alvarez-Breckenridge C, Camarda N, Lastrapes M, McCabe D, ... ... Brastianos P, et al. Gene-63. Genomic Characterization Of Human Brain Metastases Identifies Novel Drivers Of Lung Adenocarcinoma Progression Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.465 |
0.378 |
|
| 2019 |
Brastianos P, Cohen J, Wang N, Lee E, Ligibel J, Chukwueke U, Keeley M, Oh K, White M, Gerstner E, Batchelor T, Lawrence D, Ryan DP, Iafrate AJ, Giobbie-Hurder A, et al. Cmet-33. Phase Ii Study Of Palbociclib In Brain Metastases Harboring Cdk Pathway Alterations Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.234 |
0.345 |
|
| 2019 |
Singh M, Nayyar N, Subramanian M, Brastianos P. Tmod-24. Development Of A Novel In Vivo Model Of Lung-To-Brain Metastasis Progression Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.1123 |
0.345 |
|
| 2018 |
Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, ... ... Brastianos PK, et al. The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma. Acta Neuropathologica. PMID 30584643 DOI: 10.1007/S00401-018-1952-6 |
0.319 |
|
| 2018 |
Kotecha R, Gondi V, Ahluwalia MS, Brastianos PK, Mehta MP. Recent advances in managing brain metastasis. F1000research. 7. PMID 30473769 DOI: 10.12688/f1000research.15903.1 |
0.314 |
|
| 2018 |
Aquilanti E, Miller J, Santagata S, Cahill DP, Brastianos PK. Updates in prognostic markers for gliomas. Neuro-Oncology. 20: vii17-vii26. PMID 30412261 DOI: 10.1093/Neuonc/Noy158 |
0.383 |
|
| 2018 |
Venur VA, Santagata S, Galanis E, Brastianos PK. New molecular targets in meningiomas: the present and the future. Current Opinion in Neurology. 31: 740-746. PMID 30379704 DOI: 10.1097/Wco.0000000000000615 |
0.309 |
|
| 2018 |
Ippen FM, Colman H, van den Bent MJ, Brastianos PK. Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet? American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 158-167. PMID 30231322 DOI: 10.1200/EDBK_199247 |
0.447 |
|
| 2018 |
Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, ... ... Brastianos PK, et al. DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome. Acta Neuropathologica. PMID 30123936 DOI: 10.1007/S00401-018-1899-7 |
0.302 |
|
| 2018 |
Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, et al. Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. Nature Communications. 9: 2705. PMID 30006619 DOI: 10.1038/S41467-018-05030-W |
0.321 |
|
| 2018 |
Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, et al. Profiles of Brain Metastases: Prioritization of Therapeutic Targets. International Journal of Cancer. PMID 29923182 DOI: 10.1002/Ijc.31624 |
0.431 |
|
| 2018 |
Brastianos PK, Ippen FM, Hafeez U, Gan HK. Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies. The Oncologist. PMID 29703764 DOI: 10.1634/theoncologist.2017-0614 |
0.342 |
|
| 2018 |
Berghoff AS, Brastianos PK. Toward Precision Medicine in Brain Metastases. Seminars in Neurology. 38: 95-103. PMID 29548056 DOI: 10.1055/s-0038-1627469 |
0.352 |
|
| 2018 |
Valiente M, Ahluwalia MS, Boire A, Brastianos PK, Goldberg SB, Lee EQ, Le Rhun E, Preusser M, Winkler F, Soffietti R. The Evolving Landscape of Brain Metastasis. Trends in Cancer. 4: 176-196. PMID 29506669 DOI: 10.1016/J.Trecan.2018.01.003 |
0.335 |
|
| 2018 |
Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K, Manno A, Kuzan-Fischer C, Nor C, Donovan LK, Liu J, ... ... Brastianos PK, et al. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Cell. 172: 1050-1062.e14. PMID 29474906 DOI: 10.1016/J.Cell.2018.01.038 |
0.357 |
|
| 2018 |
Mitra D, Shih HA, Oh K, Brastianos P, Wo JY, Curry W, Clark JW, Parikh A, Corcoran RB, Ryan DP, Lennerz JK, Hong TS. HER2 positivity in brain metastases from gastrointestinal primary malignancies. Journal of Clinical Oncology. 36: 61-61. DOI: 10.1200/Jco.2018.36.4_Suppl.61 |
0.406 |
|
| 2018 |
Steeg P, Lyle T, Paranjapee A, Lockman P, Duchnowska R, Brastianos P, Peer C, Figg W, Pauly G, Schneider J, Smith Q, Gril B. Abstract P1-01-01: The blood-Tumor barrier as a therapeutic target to improve therapy of brain metastases of breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-01-01 |
0.305 |
|
| 2018 |
Alvarez-Breckenridge C, Stocking J, Lastrapes M, Nayyar N, Gill CM, Bertalan M, Kaplan A, McCabe D, Horbinski C, Zakaria R, Nassiri F, Zadeh G, Alvarez MM, Nahed BV, Curry WT, ... ... Brastianos P, et al. 218 Divergent Clonal Evolution of Melanoma Brain Metastases in Response to Immunotherapy Neurosurgery. 65: 121-122. DOI: 10.1093/Neuros/Nyy303.218 |
0.407 |
|
| 2018 |
Fritchie K, Jensch K, Jenkins S, Link M, D Brown P, Rodriguez F, Guajardo A, Brat D, Velazquez Vega J, Perry A, Wu A, Raleigh D, Santagata S, Louis D, Brastianos P, et al. RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA Neuro-Oncology. 20: vi237-vi238. DOI: 10.1093/Neuonc/Noy148.985 |
0.444 |
|
| 2018 |
Fujio S, Juratli T, Arita K, Hirano H, Nagano Y, Takajo T, Curry W, Jones P, Martinez-Lage M, Cahill D, Barker F, Brastianos P. Nimg-64. A Clinical Rule For Preoperative Prediction Of Braf Mutation Status In Craniopharyngiomas Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.788 |
0.315 |
|
| 2018 |
Gerstner E, Cardona J, Chang K, Beers A, Brown J, Kalpathy-Cramer J, Lee E, Lin N, Tolaney S, Nayak L, Chukwueke U, Oh K, Shih H, White M, Lawrence D, ... ... Brastianos P, et al. Nimg-63. Advanced Imaging For Assessing Volumetric Responses In Brain Metastases Treated With Checkpoint Blockade Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.787 |
0.341 |
|
| 2018 |
Alvarez-Breckenridge C, Izar B, Stocking J, Lastrapes M, Nayyar N, Gill C, Bertalan M, Kaplan A, McCabe D, Johnson D, Horbinski C, Zakaria R, Nassiri F, Zadeh G, Fisher D, ... ... Brastianos P, et al. GENE-18. DIVERGENT CLONAL EVOLUTION OF MELANOMA BRAIN METASTASES DURING TREATMENT WITH IMMUNOTHERAPY Neuro-Oncology. 20: vi106-vi107. DOI: 10.1093/Neuonc/Noy148.444 |
0.395 |
|
| 2018 |
Strickland M, Bertalan M, Kuter B, Juratli T, Melchert V, Higgins N, Toups M, Kaplan A, Bihun I, Nayyar N, Martinez-Lage M, Borger D, Shih H, Hong T, Brastianos P. CMET-15. WHOLE EXOME SEQUENCING OF BRAIN METASTASES FROM COLORECTAL PRIMARY CANCERS REVEALS CLINICALLY ACTIONABLE MUTATIONS Neuro-Oncology. 20: vi56-vi56. DOI: 10.1093/Neuonc/Noy148.227 |
0.449 |
|
| 2018 |
Ippen F, Alvarez-Breckenridge C, Kuter B, Fink A, Bihun I, Penson T, Ning J, Wakimoto H, Brastianos P. CSIG-29. THE DUAL PI3K/mTOR-PATHWAY INHIBITOR GDC-0084 ACHIEVES ANTITUMOR ACTIVITY IN BREAST CANCER BRAIN METASTASES IN VITRO AND IN VIVO Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.195 |
0.342 |
|
| 2018 |
Ratner E, Bala M, Louie-Gao M, Hazard S, Brastianos P. Brain metastases in primary ovarian cancer: Real-world data. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy285.154 |
0.381 |
|
| 2017 |
Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill CM, Kaneb A, D'Andrea M, Le LP, Lee J, Cheng J, Zheng Z, Butler WE, Multani P, Chow Maneval E, Ha Paek S, Toyota BD, ... ... Brastianos PK, et al. Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. Npj Precision Oncology. 1: 5. PMID 29872694 DOI: 10.1038/s41698-017-0009-y |
0.406 |
|
| 2017 |
Han CH, Brastianos PK. Genetic Characterization of Brain Metastases in the Era of Targeted Therapy. Frontiers in Oncology. 7: 230. PMID 28993799 DOI: 10.3389/fonc.2017.00230 |
0.434 |
|
| 2017 |
Chukwueke UN, Brastianos PK. Sequencing brain metastases and opportunities for targeted therapies. Pharmacogenomics. PMID 28290769 DOI: 10.2217/pgs-2016-0170 |
0.355 |
|
| 2017 |
Paranjape AN, Gril B, Woditschka S, Hua E, Hanson JC, Wu X, Duchnowska R, Brastianos PK, Liewehr DL, Steinberg SM, Peer C, Figg WD, Pauly GT, Robinson C, Schneider JP, et al. Abstract 4330: Astrocytic S1P3 regulates blood-brain/tumor barrier permeability Cancer Research. 77: 4330-4330. DOI: 10.1158/1538-7445.Am2017-4330 |
0.361 |
|
| 2017 |
Juratli TA, Shankar G, Koerner M, Tummala S, Wakimoto H, Krex D, Schackert G, Brastianos P, Kirsch M, Cahill DP. 151 TERT Promoter Mutations in Progressive Treatment-resistant Meningiomas Neurosurgery. 64: 236-237. DOI: 10.1093/Neuros/Nyx417.151 |
0.311 |
|
| 2017 |
Zhai L, Ladomersky E, Lauing K, Wu M, Genet M, Gritsina G, Gyorffy B, Brastianos P, Binder D, Sosman J, Giles F, James CD, Horbinski CM, Stupp R, Wainwright D. IMMU-66. IDO1 EXPRESSION STRATIFIES PATIENT SURVIVAL AND IS REGULATED BY TUMOR INFILTRATING T CELLS IN HUMAN GLIOBLASTOMA Neuro-Oncology. 19: vi127-vi127. DOI: 10.1093/Neuonc/Nox168.523 |
0.37 |
|
| 2017 |
Alvarez-Breckenridge C, Giobbie-Hurder A, Gill C, Bertalan M, Stocking J, Kaplan A, Nayyar N, Lawrence D, Flaherty K, Shih H, Oh K, Batchelor T, Cahill D, Sullivan R, Brastianos P. Cmet-16. The Role Of Surgical Resection Of Melanoma Brain Metastases In The Immunotherapy Era Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.165 |
0.404 |
|
| 2017 |
Gril B, Paranjape AN, Woditschka S, Hanson J, Wu X, Duchnowska R, Brastianos PK, Peer C, Figg WD, Pauly GT, Schneider JP, Steeg P. TMIC-19. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES Neuro-Oncology. 19: vi247-vi247. DOI: 10.1093/Neuonc/Nox168.1009 |
0.313 |
|
| 2016 |
Dagogo-Jack I, Carter SL, Brastianos PK. Brain Metastasis: Clinical Implications of Branched Evolution. Trends in Cancer. 2: 332-337. PMID 28741536 DOI: 10.1016/j.trecan.2016.06.005 |
0.348 |
|
| 2016 |
Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, ... ... Brastianos PK, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro-Oncology. PMID 28170043 DOI: 10.1093/Neuonc/Now235 |
0.559 |
|
| 2016 |
Castro BA, Kuang R, Brastianos PK. Novel approaches in genetic characterization and targeted therapy for brain metastases. Discovery Medicine. 22: 237-250. PMID 28009966 |
0.35 |
|
| 2016 |
Strickland MR, Gill CM, Nayyar N, D'Andrea MR, Thiede C, Juratli TA, Schackert G, Borger DR, Santagata S, Frosch MP, Cahill DP, Brastianos PK, Barker FG. Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. Journal of Neurosurgery. 1-7. PMID 27885953 DOI: 10.3171/2016.8.Jns161076 |
0.323 |
|
| 2016 |
Dagogo-Jack I, Gill CM, Cahill DP, Santagata S, Brastianos PK. Treatment of brain metastases in the modern genomic era. Pharmacology & Therapeutics. PMID 27773784 DOI: 10.1016/J.Pharmthera.2016.10.011 |
0.411 |
|
| 2016 |
Bi WL, Horowtiz P, Greenwald N, Abedalthagafi M, Agarwalla PK, Gibson WJ, Mei Y, Schumacher SE, Ben-David U, Chevalier A, Carter SL, Tiao G, Brastianos PK, Ligon AH, Ducar M, et al. Landscape of genomic alterations in pituitary adenomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27707790 DOI: 10.1158/1078-0432.Ccr-16-0790 |
0.574 |
|
| 2016 |
Chukwueke U, Batchelor T, Brastianos P. Management of Brain Metastases in Patients With Melanoma. Journal of Oncology Practice / American Society of Clinical Oncology. 12: 536-42. PMID 27288470 DOI: 10.1200/Jop.2016.011882 |
0.453 |
|
| 2016 |
Lyle LT, Lockman PR, Adkins CE, Mohammad AS, Sechrest E, Hua E, Palmieri D, Liewehr DJ, Steinberg SM, Kloc W, Izycka-Swieszewska E, Duchnowska R, Nayyar N, Brastianos PK, Steeg PS, et al. Alterations in Pericyte Subpopulations are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27245829 DOI: 10.1158/1078-0432.CCR-15-1836 |
0.331 |
|
| 2016 |
Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, Listewnik ML, Dias-Santagata D, Thorner AR, Van Hummelen P, Brastianos PK, Reardon DA, Wen PY, Al-Mefty O, Ramkissoon SH, et al. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-Oncology. PMID 26826201 DOI: 10.1093/Neuonc/Nov316 |
0.52 |
|
| 2016 |
Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka DJ, Sullivan RJ, Frederick DT, Abedalthagafi M, Jones PS, Dunn IF, Nahed BV, Romero JM, Louis DN, Getz G, et al. Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. Journal of the National Cancer Institute. 108. PMID 26498373 DOI: 10.1093/Jnci/Djv310 |
0.513 |
|
| 2016 |
Juratli T, Kirsch M, Thiede C, Krex D, Krause M, Brastianos P, Cahill D, Schackert G. Mngo-12. Clonal Selection Toward Tert Promoter Mutations In Progressive Recurrent Meningiomas Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.433 |
0.352 |
|
| 2015 |
Brastianos PK, Santagata S. ENDOCRINE TUMOURS: BRAF V600E mutations in papillary craniopharyngioma. European Journal of Endocrinology / European Federation of Endocrine Societies. PMID 26563980 DOI: 10.1530/Eje-15-0957 |
0.397 |
|
| 2015 |
Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, et al. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discovery. PMID 26410082 DOI: 10.1158/2159-8290.Cd-15-0369 |
0.674 |
|
| 2015 |
Shankar GM, Francis JM, Rinne ML, Ramkissoon SH, Huang FW, Venteicher AS, Akama-Garren EH, Kang YJ, Lelic N, Kim JC, Brown LE, Charbonneau SK, Golby AJ, Sekhar Pedamallu C, Hoang MP, ... ... Brastianos PK, et al. Rapid Intraoperative Molecular Characterization of Glioma. Jama Oncology. PMID 26181761 DOI: 10.1001/Jamaoncol.2015.0917 |
0.432 |
|
| 2015 |
Neagu MR, Gill CM, Batchelor TT, Brastianos PK. Genomic profiling of brain metastases: current knowledge and new frontiers. Chinese Clinical Oncology. 4: 22. PMID 26112808 DOI: 10.3978/j.issn.2304-3865.2015.06.04 |
0.314 |
|
| 2015 |
Calligaris D, Feldman DR, Norton I, Brastianos PK, Dunn IF, Santagata S, Agar NY. Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making. International Journal of Mass Spectrometry. 377: 690-698. PMID 25844057 DOI: 10.1016/J.Ijms.2014.06.024 |
0.473 |
|
| 2015 |
Du Z, Abedalthagafi M, Aizer AA, McHenry AR, Sun HH, Bray MA, Viramontes O, Machaidze R, Brastianos PK, Reardon DA, Dunn IF, Freeman GJ, Ligon KL, Carpenter AE, Alexander BM, et al. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 6: 4704-16. PMID 25609200 DOI: 10.18632/Oncotarget.3082 |
0.446 |
|
| 2015 |
Sevenich L, Bowman R, Mason S, Quail D, Rapaport F, Elie B, Brogi E, Brastianos P, Hahn W, Holsinger L, Massagué J, Leslie C, Joyce JA. Abstract IA18: A brain metastasis-promoting role for cathepsin S identified from analysis of tumor- and stroma-supplied proteolytic networks Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Ia18 |
0.622 |
|
| 2015 |
Brastianos PK, Carter SL, Santagata S, Taylor-Weiner A, Jones RT, Allen EV, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Cahill D, Curry WT, Dunn IF, Paek SH, Hummelen PV, et al. Abstract 4727: Genomic characterization of brain metastases reveals divergent evolution and metastasis specific mutations Brain. 75: 4727-4727. DOI: 10.1158/1538-7445.Am2015-4727 |
0.673 |
|
| 2015 |
Nigim F, Rabkin SD, Brastianos P, Ramesh V, Cahill D, Santagata S, Martuza RL, Wakimoto H. MNGO-16ESTABLISHMENT OF A PATIENT - DERIVED ORTHOTOPIC MALIGNANT MENINGIOMA MODEL FOR THE DEVELOPMENT OF TARGETED THERAPY Neuro-Oncology. 17: v133.2-v133. DOI: 10.1093/Neuonc/Nov220.15 |
0.481 |
|
| 2015 |
Aquilanti E, Gill C, Santagata S, Lawrence D, Flaherty K, Cahill D, Sullivan R, Brastianos P. BMET-04LEPTOMENINGEAL CARCINOMATOSIS IN MELANOMA Neuro-Oncology. 17: v45.4-v45. DOI: 10.1093/Neuonc/Nov208.04 |
0.33 |
|
| 2015 |
Brastianos P, Carter S, Santagata S, Cahill D, Taylor-Weiner A, Jones R, Ligon K, Tabernero J, Seoane J, Martinez Saez E, Johnson B, Choueiri T, Stemmer-Rachamimov A, Lin N, Beroukhim R, et al. 2905 Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets European Journal of Cancer. 51: S586. DOI: 10.1016/S0959-8049(16)31622-7 |
0.619 |
|
| 2014 |
Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, ... ... Brastianos PK, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathologica Communications. 2: 167. PMID 25589003 DOI: 10.1186/S40478-014-0167-X |
0.339 |
|
| 2014 |
Abedalthagafi MS, Merrill PH, Bi WL, Jones RT, Listewnik ML, Ramkissoon SH, Thorner AR, Dunn IF, Beroukhim R, Alexander BM, Brastianos PK, Francis JM, Folkerth RD, Ligon KL, Van Hummelen P, et al. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 5: 10596-606. PMID 25347344 DOI: 10.18632/Oncotarget.2517 |
0.462 |
|
| 2014 |
Berghoff AS, Bartsch R, Wöhrer A, Streubel B, Birner P, Kros JM, Brastianos PK, von Deimling A, Preusser M. Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues. Acta Neuropathologica. 128: 879-91. PMID 25287912 DOI: 10.1007/s00401-014-1350-7 |
0.382 |
|
| 2014 |
Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J, Leslie CS, Joyce JA. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nature Cell Biology. 16: 876-88. PMID 25086747 DOI: 10.1038/Ncb3011 |
0.502 |
|
| 2014 |
Pier DB, Nunes FP, Plotkin SR, Stemmer-Rachamimov AO, Kim JC, Shih HA, Brastianos P, Lin AE. Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome. European Journal of Medical Genetics. 57: 269-74. PMID 24675142 DOI: 10.1016/J.Ejmg.2014.03.005 |
0.318 |
|
| 2014 |
Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nature Genetics. 46: 161-5. PMID 24413733 DOI: 10.1038/Ng.2868 |
0.663 |
|
| 2014 |
Brastianos PK, Carter SL, Santagata S, Taylor-Weiner A, Jones RT, Horowitz PM, Ligon KL, Seaone J, Martinez-Saez E, Tabernero J, Cahill DP, Paek S, Dunn IF, Johnson BE, Choueiri TK, et al. Abstract NG03: Genomic characterization of 101 brain metastases and paired primary tumors reveals patterns of clonal evolution and selection of driver mutations Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ng03 |
0.713 |
|
| 2014 |
Taylor-Weiner AN, Brastianos PK, Manley PE, Jones RT, Dias-Sangata D, Thorner A, Rodriguez F, Bernardo L, Schubert L, Stewart C, Keiran M, Hahn WC, Resnick A, Louis D, Sangata S, et al. Abstract 935: Exome sequencing reveals BRAF mutations in papillary craniopharyngiomas Cancer Research. 74: 935-935. DOI: 10.1158/1538-7445.Am2014-935 |
0.565 |
|
| 2014 |
Carter SL, Brastianos PK, McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Cibulskis K, Jacks T, Hahn W, Getz G. Abstract 3992: Modes of metastasis evolution in human and murine cancer revealed by whole exome sequencing Cancer Research. 74: 3992-3992. DOI: 10.1158/1538-7445.Am2014-3992 |
0.541 |
|
| 2014 |
Brastianos P, Taylor-Weiner A, Manley P, Jones R, Dias-Santagata D, Thorner A, Rodriguez F, Bernardo L, Schubert L, Stewart C, Kieran M, Louis D, Getz G, Santagata S. GE-05 * EXOME SEQUENCING REVEALS BRAF MUTATIONS IN PAPILLARY CRANIOPHARYNGIOMAS Neuro-Oncology. 16: v97-v97. DOI: 10.1093/Neuonc/Nou256.5 |
0.503 |
|
| 2014 |
Brastianos P, Carter S, Santagata S, Taylor-Weiner A, Jones R, Van Allen E, Horowitz P, Ligon K, Cahill D, Dunn I, Van Hummelen P, Lin N, Curry W, Stemmer-Rachamimov A, Beroukhim R, et al. BM-07 * GENOMIC CHARACTERIZATION OF BRAIN METASTASES REVEALS BRANCHED EVOLUTION AND METASTASIS-SPECIFIC MUTATIONS Neuro-Oncology. 16: v33-v33. DOI: 10.1093/Neuonc/Nou240.7 |
0.727 |
|
| 2013 |
Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, et al. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proceedings of the National Academy of Sciences of the United States of America. 110: 8188-93. PMID 23633565 DOI: 10.1073/Pnas.1300252110 |
0.608 |
|
| 2013 |
Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, Stemmer-Rachamimov AO, Louis DN, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nature Genetics. 45: 285-9. PMID 23334667 DOI: 10.1038/Ng.2526 |
0.67 |
|
| 2013 |
Brastianos P, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon K, Hummelen PV, Ducar M, Raza A, Sunkavalli A, MacConaill L, Stemmer-Rachamimov A, Louis DN, Hahn WC, et al. Abstract 803: Genomic sequencing of meningiomas reveals oncogenic SMO and AKT1 mutations. Cancer Research. 73: 803-803. DOI: 10.1158/1538-7445.Am2013-803 |
0.699 |
|
| 2012 |
Brastianos PK, Horowitz P, Santagata S, Jones RT, McKenna A, Ligon K, Palescandolo E, Van Hummelen P, Getz G, Hahn WC, Dunn IF, Beroukhim R. Genomic characterization of meningiomas. Journal of Clinical Oncology. 30: 2020-2020. DOI: 10.1200/Jco.2012.30.15_Suppl.2020 |
0.671 |
|
| 2012 |
Erlich RL, Palescandolo E, Jones RT, Sunkavalli A, Raza A, Ducar M, Hatton C, Go C, Roden C, Hanna M, Mills A, Adusumilli R, Kumar P, Brastianos PK, Meyerson ML, et al. Massively parallel sequencing of formalin-fixed paraffin-embedded tissues Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-P40 |
0.369 |
|
| 2005 |
Amundson E, Pradilla G, Brastianos P, Bagley C, Riley LH, Garonzik IM, McCarthy E, Wolinsky JP, Gokaslan ZL. A novel intravertebral tumor model in rabbits. Neurosurgery. 57: 341-6; discussion 34. PMID 16094165 DOI: 10.1227/01.Neu.0000166683.67906.B7 |
0.346 |
|
| 2005 |
Brastianos P, Pradilla G, McCarthy E, Gokaslan ZL. Solitary thoracic osteochondroma: case report and review of the literature. Neurosurgery. 56: E1379; discussion E1. PMID 15918958 DOI: 10.1227/01.Neu.0000159718.69601.Ac |
0.336 |
|
| 2003 |
Zileli M, Hoscoskun C, Brastianos P, Sabah D. Surgical treatment of primary sacral tumors: complications associated with sacrectomy. Neurosurgical Focus. 15: E9. PMID 15323466 DOI: 10.3171/Foc.2003.15.5.9 |
0.437 |
|
| Show low-probability matches. |